GB0503640D0 - Improvements in or relating to organic compounds - Google Patents

Improvements in or relating to organic compounds

Info

Publication number
GB0503640D0
GB0503640D0 GBGB0503640.5A GB0503640A GB0503640D0 GB 0503640 D0 GB0503640 D0 GB 0503640D0 GB 0503640 A GB0503640 A GB 0503640A GB 0503640 D0 GB0503640 D0 GB 0503640D0
Authority
GB
United Kingdom
Prior art keywords
relating
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0503640.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Syngenta Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngenta Ltd filed Critical Syngenta Ltd
Priority to GBGB0503640.5A priority Critical patent/GB0503640D0/en
Publication of GB0503640D0 publication Critical patent/GB0503640D0/en
Priority to PCT/GB2006/000587 priority patent/WO2006090127A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0503640.5A 2005-02-22 2005-02-22 Improvements in or relating to organic compounds Ceased GB0503640D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0503640.5A GB0503640D0 (en) 2005-02-22 2005-02-22 Improvements in or relating to organic compounds
PCT/GB2006/000587 WO2006090127A1 (en) 2005-02-22 2006-02-20 Pharmaceutical formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0503640.5A GB0503640D0 (en) 2005-02-22 2005-02-22 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
GB0503640D0 true GB0503640D0 (en) 2005-03-30

Family

ID=34401123

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0503640.5A Ceased GB0503640D0 (en) 2005-02-22 2005-02-22 Improvements in or relating to organic compounds

Country Status (2)

Country Link
GB (1) GB0503640D0 (en)
WO (1) WO2006090127A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133001A (en) * 1959-11-26 1964-05-12 Muset Pedro Puig Stabilization of enzymes
US3637640A (en) * 1970-05-04 1972-01-25 Diagnostic Data Inc Orgotein stabilized with saccharide process and products
AU3643497A (en) * 1996-06-28 1998-01-21 National Jewish Center For Immunology And Respiratory Medicine Use of thioredoxin-like molecules for induction of mnsod to treat oxidative damage
US6541606B2 (en) * 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them

Also Published As

Publication number Publication date
WO2006090127A1 (en) 2006-08-31

Similar Documents

Publication Publication Date Title
GB0615358D0 (en) Improvements in or relating to organic compounds
GB0708141D0 (en) Improvements in or relating to organic compounds
GB0600913D0 (en) Improvements in or relating to organic compounds
GB0622818D0 (en) Improvements in or relating to organic compounds
AP2713A (en) Improvements in or relating to organic compounds
ZA200701558B (en) Improvements in or relating to organic compositions
EG26192A (en) Improvements in or relating to organic compounds
GB0625646D0 (en) Improvements in or relating to organic compounds
GB0714790D0 (en) Improvements in or relating to organic compounds
GB0601036D0 (en) Improvements in or related to organic compositions
GB2426239B (en) Improvements in or relating to stairlifts
GB0518558D0 (en) Improvements in or related to organic compounds
GB0426010D0 (en) Improvements in or relating to organic materials
GB0526279D0 (en) Improvements in or related to organic compounds
ZA200810428B (en) Improvements in or relating to organic compounds
GB0413500D0 (en) Improvements in or relating to organic compounds
GB0510463D0 (en) Improvements in or relating to organic materials
GB0709886D0 (en) Improvements in or relating to organic compounds
GB0500768D0 (en) Improvements in or relating to organic compounds
GB0504426D0 (en) Improvements in or relating to organic compounds
GB0523288D0 (en) Improvements in or relating to organic compounds
GB0503640D0 (en) Improvements in or relating to organic compounds
GB0407071D0 (en) Improvements in or relating to organic compounds
GB0413114D0 (en) Improvements in or relating to organic compounds
GB2428664B (en) Improvements in or relating to stairlifts

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)